VKTX - What's Going On With Viking Therapeutics Shares Tuesday? | Benzinga
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company presented new data from its Phase 2b study of VK2809.
What To Know: Viking Therapeutics said its novel liver-selective thyroid hormone receptor beta agonist VK2809 showed statistically significant reductions in liver fat content from baseline to week 12 as compared with placebo.
Viking also said newly reported findings demonstrated ...